IRMD
Price
$53.12
Change
+$0.39 (+0.74%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
557.04M
6 days until earnings call
PLSE
Price
$19.26
Change
+$1.08 (+5.94%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
481.01M
13 days until earnings call
Ad is loading...

IRMD vs PLSE

Header iconIRMD vs PLSE Comparison
Open Charts IRMD vs PLSEBanner chart's image
iRadimed
Price$53.12
Change+$0.39 (+0.74%)
Volume$100
Capitalization557.04M
Pulse Biosciences
Price$19.26
Change+$1.08 (+5.94%)
Volume$2.78K
Capitalization481.01M
IRMD vs PLSE Comparison Chart
Loading...
IRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IRMD vs. PLSE commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRMD is a Buy and PLSE is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (IRMD: $52.73 vs. PLSE: $18.22)
Brand notoriety: IRMD and PLSE are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IRMD: 98% vs. PLSE: 122%
Market capitalization -- IRMD: $557.04M vs. PLSE: $481.01M
IRMD [@Medical Specialties] is valued at $557.04M. PLSE’s [@Medical Specialties] market capitalization is $481.01M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IRMD’s FA Score shows that 2 FA rating(s) are green whilePLSE’s FA Score has 0 green FA rating(s).

  • IRMD’s FA Score: 2 green, 3 red.
  • PLSE’s FA Score: 0 green, 5 red.
According to our system of comparison, IRMD is a better buy in the long-term than PLSE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IRMD’s TA Score shows that 5 TA indicator(s) are bullish while PLSE’s TA Score has 6 bullish TA indicator(s).

  • IRMD’s TA Score: 5 bullish, 2 bearish.
  • PLSE’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, IRMD is a better buy in the short-term than PLSE.

Price Growth

IRMD (@Medical Specialties) experienced а +1.48% price change this week, while PLSE (@Medical Specialties) price change was +7.87% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +4.26%. For the same industry, the average monthly price growth was -6.64%, and the average quarterly price growth was -2.53%.

Reported Earning Dates

IRMD is expected to report earnings on Jul 31, 2025.

PLSE is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Medical Specialties (+4.26% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IRMD($557M) has a higher market cap than PLSE($481M). PLSE YTD gains are higher at: 4.652 vs. IRMD (-3.107). IRMD has higher annual earnings (EBITDA): 20.8M vs. PLSE (-42.37M). IRMD has more cash in the bank: 49.8M vs. PLSE (44.4M). IRMD has less debt than PLSE: IRMD (2.04M) vs PLSE (9.14M). IRMD has higher revenues than PLSE: IRMD (65.6M) vs PLSE (0).
IRMDPLSEIRMD / PLSE
Capitalization557M481M116%
EBITDA20.8M-42.37M-49%
Gain YTD-3.1074.652-67%
P/E Ratio31.84N/A-
Revenue65.6M0-
Total Cash49.8M44.4M112%
Total Debt2.04M9.14M22%
FUNDAMENTALS RATINGS
IRMD vs PLSE: Fundamental Ratings
IRMD
PLSE
OUTLOOK RATING
1..100
2417
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
59
Fair valued
PROFIT vs RISK RATING
1..100
2672
SMR RATING
1..100
4095
PRICE GROWTH RATING
1..100
5137
P/E GROWTH RATING
1..100
35100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IRMD's Valuation (16) in the Medical Specialties industry is somewhat better than the same rating for PLSE (59). This means that IRMD’s stock grew somewhat faster than PLSE’s over the last 12 months.

IRMD's Profit vs Risk Rating (26) in the Medical Specialties industry is somewhat better than the same rating for PLSE (72). This means that IRMD’s stock grew somewhat faster than PLSE’s over the last 12 months.

IRMD's SMR Rating (40) in the Medical Specialties industry is somewhat better than the same rating for PLSE (95). This means that IRMD’s stock grew somewhat faster than PLSE’s over the last 12 months.

PLSE's Price Growth Rating (37) in the Medical Specialties industry is in the same range as IRMD (51). This means that PLSE’s stock grew similarly to IRMD’s over the last 12 months.

IRMD's P/E Growth Rating (35) in the Medical Specialties industry is somewhat better than the same rating for PLSE (100). This means that IRMD’s stock grew somewhat faster than PLSE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IRMDPLSE
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 10 days ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
59%
Bearish Trend 24 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
72%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
IRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DIVPX15.550.21
+1.37%
MAI Managed Volatility Investor
CDWCX10.960.08
+0.74%
American Funds Dvlpg Wld Gr&Inc 529C
CMCIX24.23N/A
N/A
Calvert Small/Mid-Cap I
PEIOX36.88N/A
N/A
Principal Equity Income R3
FIKEX47.44N/A
N/A
Fidelity Advisor Industrials Z

IRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRMD has been loosely correlated with HBIO. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if IRMD jumps, then HBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRMD
1D Price
Change %
IRMD100%
+0.76%
HBIO - IRMD
46%
Loosely correlated
-2.06%
VREX - IRMD
43%
Loosely correlated
+9.34%
AORT - IRMD
43%
Loosely correlated
+0.29%
ITGR - IRMD
41%
Loosely correlated
+0.79%
SIBN - IRMD
40%
Loosely correlated
+4.12%
More

PLSE and

Correlation & Price change

A.I.dvisor tells us that PLSE and IRMD have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PLSE and IRMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLSE
1D Price
Change %
PLSE100%
-0.27%
IRMD - PLSE
33%
Poorly correlated
+1.23%
CERS - PLSE
32%
Poorly correlated
N/A
QDEL - PLSE
28%
Poorly correlated
+5.19%
HBIO - PLSE
28%
Poorly correlated
+0.97%
INMD - PLSE
27%
Poorly correlated
-0.32%
More